33.5 C
New York
Friday, June 12, 2026

Tag: milk

newssourceFORcompanyinformationcontent1marketreleases

Brooklyn Dumpling Shop Launches Investment Round Led by RSE Ventures to Further Accelerate Growth Across Restaurants, Consumer Products, and Foodservice

NEW YORK, July 11, 2025 /PRNewswire/ -- Brooklyn Dumpling Shop, the high-growth culinary-driven concept providing distinct takes on classic menu items and Asian-inspired cuisine, today...

Freeze the Day — It’s Slurpee Day at 7-Eleven, Inc.!

Everyone is invited to sip and celebrate with free Slurpee drinks, colorful Tongue-toos and delicious deals IRVING, Texas, July 11, 2025 /PRNewswire/ -- The wait...

Hangyo Ice Creams Expands Production Capacity as Demand Soars Across Southern India

MANGALORE, India, July 11, 2025 /PRNewswire/ -- Hangyo Ice Creams Pvt. Ltd., one of South India's Ice Cream brands, is ramping up operations to meet...

The J.M. Smucker Co. Announces the Planned Retirement of Gail Hollander, Chief Marketing Officer

ORRVILLE, Ohio, July 10, 2025 /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced the planned retirement of Gail Hollander, Chief Marketing Officer, effective...

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

COPENHAGEN, Denmark and DAVIS, Calif., July 10, 2025 /PRNewswire/ -- 21st.BIO, a leading technology partner in precision fermentation, today announced the launch of a new development...

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

COPENHAGEN, Denmark and DAVIS, Calif., July 10, 2025 /PRNewswire/ -- 21st.BIO, a leading technology partner in precision fermentation, today announced the launch of a new development...

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

COPENHAGEN, Denmark and DAVIS, Calif., July 10, 2025 /PRNewswire/ -- 21st.BIO, a leading technology partner in precision fermentation, today announced the launch of a new development...

Junlebao Chooses APV to Expand Shelf-Stable Milk Capacity into Southern China

CHARLOTTE, N.C., July 10, 2025 /PRNewswire/ -- APV, an SPX FLOW brand, and Junlebao Dairy, one of China's fastest–growing dairy companies are partnering to design...

Junlebao Chooses APV to Expand Shelf-Stable Milk Capacity into Southern China

CHARLOTTE, N.C., July 9, 2025 /PRNewswire/ -- APV, an SPX FLOW brand, and Junlebao Dairy, one of China's fastest–growing dairy companies are partnering to design...

BCC Research Releases 2024 Protein Synthesis Research Review

"Driving Innovation and Sustainability: The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market...

BCC Research Releases 2024 Protein Synthesis Research Review

"Driving Innovation and Sustainability: The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market...

RECKITT BENCKISER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead...

NEW YORK and NEW ORLEANS, July 08, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), if they purchased the Company’s American Depositary Shares (“ADSs”) between January 13, 2021 and July 28, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors...

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMilk

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers